← back to search

Scott Barker

Royal Veterinary College · GB
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, and Colorectal Cancer Treatments and Studies.
h-index
8
citations
432
works
28
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Selpercatinib in <i>RET</i> Fusion–Positive Non–Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial
Journal of Clinical Oncology 2025cited by 22position: middledoi
Selpercatinib in Patients With <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial
Journal of Clinical Oncology 2022cited by 199position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Benjamin Solomon · Peter MacCallum Cancer Centre2 papers (2022–2025)Pascale Tomasini · Centre de Recherche en Cancérologie de Marseille2 papers (2022–2025)Alexander Drilon · Université Grenoble Alpes2 papers (2022–2025)Oliver Gautschi · University of Bern2 papers (2022–2025)Filippo de Braud · National Cancer Institute2 papers (2022–2025)Keunchil Park · The University of Texas MD Anderson Cancer Center2 papers (2022–2025)Herbert H. Loong · Shanghai Chest Hospital2 papers (2022–2025)Kōichi Goto · Université Grenoble Alpes2 papers (2022–2025)Vivek Subbiah · International Drug Development1 papers (2022–2022)Geoffrey R. Oxnard · Boston Medical Center1 papers (2025–2025)Daniel S.W. Tan · National Cancer Centre Singapore1 papers (2022–2022)— · 1 papers (2025–2025)— · 1 papers (2025–2025)Jürgen Wolf · Université Grenoble Alpes1 papers (2022–2022)Aimee Bence Lin · Eli Lilly (United States)1 papers (2022–2022)Tarun Puri · Loxo Oncology at Lilly (United States)1 papers (2022–2022)Victoria Soldatenkova · Eli Lilly (Singapore)1 papers (2022–2022)Benjamin Besse · Institut Gustave Roussy1 papers (2022–2022)Sylwia Szymczak · Eli Lilly (United States)1 papers (2022–2022)— · 1 papers (2025–2025)